Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 9

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients

Total article views   HTML views PDF downloads Totals
12,589 Dovepress* 10,556+ 2,146 12,702
PubMed Central* 2,033 429 2,462
Totals 12,589 2,575 15,164
*Since 24 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar